Cellulose Acetate Phthalate and Antiretroviral Nanoparticle Fabrications for HIV Pre-Exposure Prophylaxis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cellulose Acetate Phthalate and Antiretroviral Nanoparticle Fabrications for HIV Pre-Exposure Prophylaxis
Authors
Keywords
-
Journal
Polymers
Volume 9, Issue 12, Pages 423
Publisher
MDPI AG
Online
2017-09-08
DOI
10.3390/polym9090423
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Topical Tenofovir Disoproxil Fumarate Nanoparticles Prevent HIV-1 Vaginal Transmission in a Humanized Mouse Model
- (2016) Christopher J. Destache et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- An Enhanced Emtricitabine-Loaded Long-Acting Nanoformulation for Prevention or Treatment of HIV Infection
- (2016) Subhra Mandal et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Thermosensitive Gel Containing Cellulose Acetate Phthalate-Efavirenz Combination Nanoparticles for Prevention of HIV-1 Infection
- (2015) Abhijit A. Date et al. Journal of Biomedical Nanotechnology
- Confocal fluorescence microscopy: An ultra-sensitive tool used to evaluate intracellular antiretroviral nano-drug delivery in HeLa cells
- (2015) Subhra Mandal et al. AIP Advances
- Simulated Biological Fluids with Possible Application in Dissolution Testing
- (2015) Margareth R. C. Marques et al. DISSOLUTION TECHNOLOGIES
- Dolutegravir: A Next-Generation Integrase Inhibitor for Treatment of HIV Infection
- (2014) D. A. Osterholzer et al. CLINICAL INFECTIOUS DISEASES
- Dolutegravir: A Review of Its Use in the Management of HIV-1 Infection in Adolescents and Adults
- (2014) Paul L. McCormack DRUGS
- Preventing HIV infection: Pre-exposure and postexposure prophylaxis
- (2014) Susanne Doblecki-Lewis et al. IUBMB LIFE
- Comparative replication capacity of raltegravir-resistant strains and antiviral activity of the new-generation integrase inhibitor dolutegravir in human primary macrophages and lymphocytes
- (2014) M. Pollicita et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study
- (2014) A. Castagna et al. JOURNAL OF INFECTIOUS DISEASES
- Dolutegravir: clinical efficacy and role in HIV therapy
- (2014) Alessandra Fantauzzi et al. Therapeutic Advances in Chronic Disease
- Assessment of topical microbicides to prevent HIV-1 transmission: Concepts, testing, lessons learned
- (2013) David R. Friend et al. ANTIVIRAL RESEARCH
- Electrospun fibers for vaginal anti-HIV drug delivery
- (2013) Anna K. Blakney et al. ANTIVIRAL RESEARCH
- Preventing HIV Infection in Women
- (2013) Adaora A. Adimora et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- The Activity of the Integrase Inhibitor Dolutegravir Against HIV-1 Variants Isolated From Raltegravir-Treated Adults
- (2012) Mark R. Underwood et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Reformulated tenofovir gel for use as a dual compartment microbicide
- (2012) C. S. Dezzutti et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Molecular Dynamics Approaches Estimate the Binding Energy of HIV-1 Integrase Inhibitors and Correlate withIn VitroActivity
- (2011) Barry C. Johnson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Dolutegravir (S/GSK1349572) Exhibits Significantly Slower Dissociation than Raltegravir and Elvitegravir from Wild-Type and Integrase Inhibitor-Resistant HIV-1 Integrase-DNA Complexes
- (2011) Kendra E. Hightower et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The rise and fall of polyanionic inhibitors of the human immunodeficiency virus type 1
- (2011) Vanessa Pirrone et al. ANTIVIRAL RESEARCH
- Electrospun cellulose acetate phthalate fibers for semen induced anti-HIV vaginal drug delivery
- (2011) Chaobo Huang et al. BIOMATERIALS
- In VitroAntiretroviral Properties of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor
- (2010) Masanori Kobayashi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Preventing mucosal HIV transmission with topical microbicides: Challenges and opportunities
- (2010) Florian Hladik et al. ANTIVIRAL RESEARCH
- Unacceptable side-effects associated with a hyperosmolar vaginal microbicide in a phase 1 trial
- (2010) C J Lacey et al. INTERNATIONAL JOURNAL OF STD & AIDS
- Antiretroviral release from poly(DL-lactide-co-glycolide) nanoparticles in mice
- (2010) C. J. Destache et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Emerging nanotechnology approaches for HIV/AIDS treatment and prevention
- (2010) Tewodros Mamo et al. Nanomedicine
- Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women
- (2010) Q. Abdool Karim et al. SCIENCE
- Microbicides and HIV prevention: lessons from the past, looking to the future
- (2009) Georgina C Morris et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors
- (2009) Erik Serrao et al. Retrovirology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now